Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled…

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study. https://t.co/HhYsgyyi89 H/T @NCBI #radonc #Pu

上咽頭癌患者に対する化学放射線療法におけるゲムシタビン＋シスプラチン療法とフルオロウラシル＋シスプラチン療法は3年無病生存率が類似していた。 https://t.co/hofJWWHOlY